Literature DB >> 18765650

MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study.

J L Whitwell1, K A Josephs, M E Murray, K Kantarci, S A Przybelski, S D Weigand, P Vemuri, M L Senjem, J E Parisi, D S Knopman, B F Boeve, R C Petersen, D W Dickson, C R Jack.   

Abstract

BACKGROUND: Neurofibrillary tangles (NFTs), composed of hyperphosphorylated tau proteins, are one of the pathologic hallmarks of Alzheimer disease (AD). We aimed to determine whether patterns of gray matter atrophy from antemortem MRI correlate with Braak staging of NFT pathology.
METHODS: Eighty-three subjects with Braak stage III through VI, a pathologic diagnosis of low- to high-probability AD, and MRI within 4 years of death were identified. Voxel-based morphometry assessed gray matter atrophy in each Braak stage compared with 20 pathologic control subjects (Braak stages 0 through II).
RESULTS: In pairwise comparisons with Braak stages 0 through II, a graded response was observed across Braak stages V and VI, with more severe and widespread loss identified at Braak stage VI. No regions of loss were identified in Braak stage III or IV compared with Braak stages 0 through II. The lack of findings in Braak stages III and IV could be because Braak stage is based on the presence of any NFT pathology regardless of severity. Actual NFT burden may vary by Braak stage. Therefore, tau burden was assessed in subjects with Braak stages 0 through IV. Those with high tau burden showed greater gray matter loss in medial and lateral temporal lobes than those with low tau burden.
CONCLUSIONS: Patterns of gray matter loss are associated with neurofibrillary tangle (NFT) pathology, specifically with NFT burden at Braak stages III and IV and with Braak stage itself at higher stages. This validates three-dimensional patterns of atrophy on MRI as an approximate in vivo surrogate indicator of the full brain topographic representation of the neurodegenerative aspect of Alzheimer disease pathology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18765650      PMCID: PMC2676950          DOI: 10.1212/01.wnl.0000324924.91351.7d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  33 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

2.  Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease.

Authors:  Matthew L Senjem; Jeffrey L Gunter; Maria M Shiung; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2005-04-12       Impact factor: 6.556

3.  Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease.

Authors:  Hiroshi Matsuda; Noriyuki Kitayama; Takashi Ohnishi; Takashi Asada; Seigo Nakano; Shigeki Sakamoto; Etsuko Imabayashi; Asako Katoh
Journal:  J Nucl Med       Date:  2002-03       Impact factor: 10.057

4.  Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images.

Authors:  N C Fox; W R Crum; R I Scahill; J M Stevens; J C Janssen; M N Rossor
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

5.  Argyrophilic grains: a distinct disease or an additive pathology?

Authors:  Keith A Josephs; Jennifer L Whitwell; Joseph E Parisi; David S Knopman; Bradley F Boeve; Yonas E Geda; Clifford R Jack; Ronald C Petersen; Dennis W Dickson
Journal:  Neurobiol Aging       Date:  2006-12-26       Impact factor: 4.673

6.  Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.

Authors:  G Chételat; B Landeau; F Eustache; F Mézenge; F Viader; V de la Sayette; B Desgranges; J-C Baron
Journal:  Neuroimage       Date:  2005-10-01       Impact factor: 6.556

7.  Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Maria M Shiung; Bradley F Boeve; Tanis J Ferman; Glenn E Smith; David S Knopman; Ronald C Petersen; Eduardo E Benarroch; Keith A Josephs; Clifford R Jack
Journal:  Brain       Date:  2007-01-31       Impact factor: 13.501

8.  Beta-amyloid burden is not associated with rates of brain atrophy.

Authors:  Keith A Josephs; Jennifer L Whitwell; Zeshan Ahmed; Maria M Shiung; Stephen D Weigand; David S Knopman; Bradley F Boeve; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson; Clifford R Jack
Journal:  Ann Neurol       Date:  2008-02       Impact factor: 10.422

9.  3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.

Authors:  Jennifer L Whitwell; Scott A Przybelski; Stephen D Weigand; David S Knopman; Bradley F Boeve; Ronald C Petersen; Clifford R Jack
Journal:  Brain       Date:  2007-05-28       Impact factor: 13.501

10.  Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons.

Authors:  Julie A Schneider; Patricia A Boyle; Zoe Arvanitakis; Julia L Bienias; David A Bennett
Journal:  Ann Neurol       Date:  2007-07       Impact factor: 10.422

View more
  170 in total

1.  Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume.

Authors:  Owen Carmichael; Jing Xie; Evan Fletcher; Baljeet Singh; Charles DeCarli
Journal:  Neurobiol Aging       Date:  2011-12-14       Impact factor: 4.673

Review 2.  Alliance for aging research AD biomarkers work group: structural MRI.

Authors:  Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

Review 3.  Quantitative structural MRI for early detection of Alzheimer's disease.

Authors:  Linda K McEvoy; James B Brewer
Journal:  Expert Rev Neurother       Date:  2010-11       Impact factor: 4.618

4.  Longitudinal changes in cortical thickness associated with normal aging.

Authors:  Madhav Thambisetty; Jing Wan; Aaron Carass; Yang An; Jerry L Prince; Susan M Resnick
Journal:  Neuroimage       Date:  2010-05-02       Impact factor: 6.556

5.  Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.

Authors:  Prashanthi Vemuri; Gyorgy Simon; Kejal Kantarci; Jennifer L Whitwell; Matthew L Senjem; Scott A Przybelski; Jeffrey L Gunter; Keith A Josephs; David S Knopman; Bradley F Boeve; Tanis J Ferman; Dennis W Dickson; Joseph E Parisi; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2010-12-31       Impact factor: 6.556

6.  Automatic voxel-based morphometry of structural MRI by SPM8 plus diffeomorphic anatomic registration through exponentiated lie algebra improves the diagnosis of probable Alzheimer Disease.

Authors:  H Matsuda; S Mizumura; K Nemoto; F Yamashita; E Imabayashi; N Sato; T Asada
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

7.  The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.

Authors:  E Cavedo; S Lista; Z Khachaturian; P Aisen; P Amouyel; K Herholz; C R Jack; R Sperling; J Cummings; K Blennow; S O'Bryant; G B Frisoni; A Khachaturian; M Kivipelto; W Klunk; K Broich; S Andrieu; M Thiebaut de Schotten; J-F Mangin; A A Lammertsma; K Johnson; S Teipel; A Drzezga; A Bokde; O Colliot; H Bakardjian; H Zetterberg; B Dubois; B Vellas; L S Schneider; H Hampel
Journal:  J Prev Alzheimers Dis       Date:  2014-12

8.  Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.

Authors:  Anja Soldan; Corinne Pettigrew; Yi Lu; Mei-Cheng Wang; Ola Selnes; Marilyn Albert; Timothy Brown; J Tilak Ratnanather; Laurent Younes; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2015-04-16       Impact factor: 5.038

9.  Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease.

Authors:  W J P Henneman; H Vrenken; J Barnes; I C Sluimer; N A Verwey; M A Blankenstein; M Klein; N C Fox; P Scheltens; F Barkhof; W M van der Flier
Journal:  Neurology       Date:  2009-09-22       Impact factor: 9.910

10.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.